These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2511796

  • 1. [The new thrombolytic agents].
    Bassand JP.
    Ann Cardiol Angeiol (Paris); 1989 Sep 30; 38(7 Pt 2):487-91. PubMed ID: 2511796
    [Abstract] [Full Text] [Related]

  • 2. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ, Grimm AM, Hopkins LE.
    Pharmacotherapy; 1990 Sep 30; 10(2):115-26. PubMed ID: 2140889
    [Abstract] [Full Text] [Related]

  • 3. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov 30; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 4. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES, Cregeen RJ.
    Drugs; 1987 Nov 30; 33 Suppl 3():298-311. PubMed ID: 3315612
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL.
    Rev Esp Cardiol; 1992 Nov 30; 45 Suppl 2():9-20. PubMed ID: 1475514
    [Abstract] [Full Text] [Related]

  • 6. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun 30; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 7. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Jun 30; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 8. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Verh K Acad Geneeskd Belg; 1989 Jun 30; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [Abstract] [Full Text] [Related]

  • 9. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec 30; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 10. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D, Bounameaux H.
    Herz; 1986 Feb 30; 11(1):9-15. PubMed ID: 3082731
    [Abstract] [Full Text] [Related]

  • 11. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA, Forrence EA.
    Clin Pharm; 1990 Jul 30; 9(7):530-40. PubMed ID: 2198125
    [Abstract] [Full Text] [Related]

  • 12. Safe use of thrombolysis in the elderly.
    Wittry MD, Thornton TA, Chaitman BR.
    Geriatrics; 1989 Nov 30; 44(11):28-30, 33-6. PubMed ID: 2509296
    [Abstract] [Full Text] [Related]

  • 13. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G, Charbonnier B.
    Arch Mal Coeur Vaiss; 1990 Feb 30; 83 Spec No 1():25-9. PubMed ID: 2108643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ.
    Am J Cardiol; 1988 Jul 01; 62(1):25-30. PubMed ID: 3289357
    [Abstract] [Full Text] [Related]

  • 17. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP, Schiele F, Bernard Y, Anguenot T.
    Arch Mal Coeur Vaiss; 1992 May 01; 85(5 Suppl):677-87. PubMed ID: 1530409
    [Abstract] [Full Text] [Related]

  • 18. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
    Julian DG, Borthwick LS, Reid D, Jennings KP, Wainwright RJ, Rodger JC, Wood D, Phillips WS.
    Drugs; 1987 May 01; 33 Suppl 3():261-7. PubMed ID: 3315604
    [Abstract] [Full Text] [Related]

  • 19. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR.
    Rev Cardiovasc Med; 2002 May 01; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [Abstract] [Full Text] [Related]

  • 20. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.
    Anderson JL.
    Drugs; 1987 May 01; 33 Suppl 3():154-62. PubMed ID: 3315584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.